HomeNewsBusinessEconomyINTERVIEW | See FY22 GDP growth at 10.5%, economic pick-up to continue: Morgan Stanley's Upasana Chachra

INTERVIEW | See FY22 GDP growth at 10.5%, economic pick-up to continue: Morgan Stanley's Upasana Chachra

In an interview with Moneycontrol, Morgan Stanley's Upasana Chachra said that the Centre was on the right track by focusing on infrastructure and public investment, and that an income-support programme might not be feasible from a fiscal deficit perspective.

June 10, 2021 / 08:42 IST
Story continues below Advertisement

In absolute terms, the gross domestic product (GDP) in the current April-June quarter may decline compared to the January-March quarter, said Upasana Chachra, Chief India Economist - Morgan Stanley, in an exclusive interaction with Moneycontrol.

However, Chachra also said that her GDP estimates for the full year were much more optimistic than other agencies, including the Reserve Bank of India. Chachra said that, while some high frequency indicators had seen a slump in the months of April and May as India was hit by a deadly second wave of the COVID-19 pandemic, and many states imposed regional lockdowns, others held up comparatively well.

Story continues below Advertisement

“I think there is reason to remain optimistic that India will and can post a double digit growth in fiscal year 2021-22,” she said. Edited Excerpts:

Q: I believe your GDP growth estimate for the year is around 10.5 percent GDP growth? What makes you more optimistic than the Reserve Bank of India, which has now cut its forecast to a 9.5 percent GDP growth

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show